Literature DB >> 15703893

Treatment of thrombotic thrombocytopenic purpura.

Menno van der Straaten, Sophie Jamart, Robert Wens, Philippe Gottignies, Max Dratwa, Jacques Devriendt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15703893     DOI： 10.1007/s00134-005-2565-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Rituximab in patients with refractory thrombotic thrombocytopenic purpura.

Authors:  S Sallah; A Husain; J Y Wan; N P Nguyen
Journal:  J Thromb Haemost       Date:  2004-05       Impact factor: 5.824

2.  Outcome of severe adult thrombotic microangiopathies in the intensive care unit.

Authors:  Frédéric Pene; Cécile Vigneau; Marc Auburtin; Delphine Moreau; Jean-Ralph Zahar; Joël Coste; Farhad Heshmati; Jean-Paul Mira
Journal:  Intensive Care Med       Date:  2004-12-03       Impact factor: 17.440

3.  Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).

Authors:  Afaq Ahmad; Anita Aggarwal; Daya Sharma; Harish P Dave; Virginia Kinsella; Margaret E Rick; Geraldine P Schechter
Journal:  Am J Hematol       Date:  2004-10       Impact factor: 10.047

4.  Treatment of resistant thrombotic thrombocytopenic purpura with rituximab and cyclophosphamide.

Authors:  Gideon Y Stein; Aliza Zeidman; Zinaida Fradin; Meir Varon; Amos Cohen; Moshe Mittelman
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.